Targeted Ablation Of Cardiac Sympathetic Neurons Attenuates Adverse Postinfarction Remodelling And Left Ventricular Dysfunction

Liang Xiong,Yu Liu,Mingmin Zhou,Guangji Wang,Dajun Quan,Wei Shuai,Caijie Shen,Bin Kong,Congxin Huang,He Huang

DOI: https://doi.org/10.1113/EP086928

2018-01-01

Experimental Physiology

Abstract:Sympathetic overactivation is crucial in the development and progression of adverse cardiac remodelling and dysfunction. Targeted ablation of cardiac sympathetic neurons (TACSN) is an effective approach to inhibit overactivation of the sympathetic nervous system. The aim of this study was to investigate whether TACSN could suppress myocardial infarction (MI)-induced adverse cardiac remodelling and dysfunction, thereby producing protective effects. Thirty-eight dogswere randomly assigned into the sham-operated, MI or MI-TACSN group. The TACSN was induced by injecting cholera toxinB subunit-saporin compound into the stellate ganglia 1week after MI. Five weeks after MI surgery, echocardiographic and haemodynamic parameters of cardiac function were significantly improved in the TACSN group compared with the MI group. In addition, TACSN attenuated the extent of cardiac hypertrophy and fibrosis and suppressed the increase in the plasma concentrations of noradrenaline, nerve growth factor, atrial natriuretic peptide, brain natriuretic peptide, angiotensinII and aldosterone. Furthermore, TACSN alleviated the growth associated protein-43-positive and tyrosine hydroxylase-positive nerve densities in the infarcted border zone and restored protein expression of the (1)-adrenergic receptor in the left ventricular myocardium. These findings indicate that TACSN might have a beneficial effect on adverse postinfarction remodelling and left ventricular dysfunction, which might be attributable, at least in part, to the attenuation of both sympathetic remodelling and the cardiac neuroendocrine system.